Biospecimen Types Available for Research and Development
Click the Distribution Data buttons to review the CHTN's collected and shipped biospecimens for the previous grant cycle; years 2019 to 2023.
COLLECTED DATASHIPPED DATA*Reminder: 2020 and 2021 data was affected by COVID.
Malignant
Representing various cancer types across multiple organ systems.
Benign
Non-cancerous growths and lesions for comparative research.
Disease
Samples from patients with non-malignant pathological conditions.
Normal, Uninvolved/Normal Adjacent Tissue (NAT)
Control samples from non-diseased regions, critical for baseline studies.
Biofluids
Including:
- Urine
- Serum
- Plasma
- Buffy coat (white blood cell fraction)
- Effusions
- PBMCs